文献速递临床试验与 GCP组学、生物样本库与精准医学

基于宏基因组分析探讨针刺对肥胖型多囊卵巢综合征女性个体化疗效差异的研究方案:随机对照试验

Differences in the individual curative effect of acupuncture for obese women with polycystic ovary syndrome based on metagenomic analysis: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2021-07-15

本研究为开放标签随机对照试验,计划纳入86例肥胖型PCOS女性,1:1随机分为针刺联合枸橼酸氯米芬组与单用枸橼酸氯米芬组,另招募10例健康对照。主要结局为LH/FSH,并采用宏基因组分析探索肠道菌群对针刺个体化疗效差异的作用。

要点

  • 针刺作为肥胖型PCOS辅助治疗的附加疗效尚未被研究。
  • 主要结局为LH/FSH,次要结局包括激素、代谢、炎症指标及焦虑抑郁量表。
  • 通过宏基因组分析探索肠道菌群与针刺疗效个体差异的关联。

核心结论

  • 本试验旨在评估针刺对肥胖型PCOS的附加疗效,并基于肠道菌群探索针刺个体化疗效差异的机制。

研究设计与样本

  • 开放标签随机对照试验,计划招募86例肥胖型PCOS女性,1:1随机分为研究组和对照组各43例。
  • 每组10例符合研究标准的患者参与宏基因组分析,另招募10例符合标准的健康对照。
  • 研究组接受针刺联合枸橼酸氯米芬治疗,对照组仅接受枸橼酸氯米芬治疗。
  • 针刺从月经或撤退性出血第5天开始,每周3次,直至下次月经来潮,最多三个月经周期。

关键数值与推荐

  • 主要结局为LH/FSH,在基线和干预后测量。
  • 次要结局包括生物特征、激素生物标志物、代谢生物标志物、炎症生物标志物、焦虑自评量表和抑郁自评量表及宏基因组分析。
  • 数据采用SPSS 19.0分析,肠道菌群采用宏基因组分析。

临床怎么用

  • 为针刺作为肥胖型PCOS辅助治疗提供疗效证据,并可能解释不同试验结果差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Polycystic ovary syndrome is a common cause of infertility and shows a high incidence in women of reproductive age. Acupuncture is an appropriate adjunctive treatment for PCOS. However, the add-on effect of acupuncture as an adjunctive treatment for obese women with PCOS has not been studied, and previous studies indicate that there are individual differences in the curative effect of acupuncture, while deeper research on the mechanism of differences in the individual curative effect of acupuncture for obese women with PCOS is still lacking. This trial aims to assess the add-on treatment efficacy of acupuncture for obese women with PCOS and to explore the role of the gut microbiome on the differences in the individual curative effect of acupuncture based on metagenomic analysis. METHODS/DESIGN: This is an open-label, randomized, controlled trial. A total of 86 obese women with PCOS will be recruited. Subjects will be randomly assigned to a study group and a control group in a 1:1 ratio, with 43 subjects in each group (10 patients from each group who meet the study criteria will participate in the metagenomic analysis). An additional 10 subjects who meet the study criteria will be recruited to a healthy control group. The study group will receive acupuncture and clomiphene citrate treatment; the control group will only receive clomiphene citrate. Acupuncture treatment will be conducted three times a week from the fifth day of menstruation or withdrawal bleeding until the start of the next menstruation, for up to three menstrual cycles. The primary outcome will be LH/FSH. The secondary outcomes will comprise biometric features, hormone biomarkers, metabolic biomarkers, inflammatory biomarkers, Self-Rating Anxiety Scale, Self-Rating Depression Scale, and metagenomic analysis. The outcomes will be measured at baseline and post-intervention. Data will be analyzed using SPSS 19.0, and the gut microbiome will be analyzed using metagenomic analysis. DISCUSSION: In this study, we are evaluating the add-on effects of acupuncture and exploring the mechanism of the differences in the individual curative effect of acupuncture based on the gut microbiome, which may provide evidence to explain the different outcomes of different trials on acupuncture for PCOS and hopefully to provide a new aspect to study the mechanism of acupuncture's treatment effect. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2000029882 . Registered on 16 February 2020.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Fan H, Hong X, Zeng J, et al. Differences in the individual curative effect of acupuncture for obese women with polycystic ovary syndrome based on metagenomic analysis: study protocol for a randomized controlled trial. Trials. 2021. PMID: 34266458. doi:10.1186/s13063-021-05426-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。